Xiamen C&D Inc
SSE:600153
Xiamen C&D Inc
SSE:600153
Price:
10.26
CNY
-1.06%
Market Closed
Market Cap:
30.2B
CNY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Xiamen C&D Inc
10.26
-0.11 (-1.06%)
| 52 Week Range |
7.06
11.45
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Xiamen C&D Inc
Balance Sheet
Balance Sheet Decomposition
Xiamen C&D Inc
Xiamen C&D Inc
| Current Assets | 709.1B |
| Cash & Short-Term Investments | 91.2B |
| Receivables | 113.6B |
| Other Current Assets | 504.3B |
| Non-Current Assets | 193.2B |
| Long-Term Investments | 152.5B |
| PP&E | 13.6B |
| Intangibles | 4B |
| Other Non-Current Assets | 23.2B |
| Current Liabilities | 524.1B |
| Accounts Payable | 68.6B |
| Accrued Liabilities | 36B |
| Short-Term Debt | 135.5B |
| Other Current Liabilities | 284B |
| Non-Current Liabilities | 307.4B |
| Long-Term Debt | 128.9B |
| Other Non-Current Liabilities | 178.5B |
Balance Sheet
Xiamen C&D Inc
Xiamen C&D Inc
Currency: CNY
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
6 643
|
9 776
|
11 032
|
16 440
|
18 851
|
35 349
|
50 445
|
84 914
|
88 757
|
85 935
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
84 914
|
88 757
|
85 935
|
|
| Cash Equivalents |
6 643
|
9 776
|
11 032
|
16 440
|
18 851
|
35 349
|
50 445
|
0
|
0
|
0
|
|
| Short-Term Investments |
328
|
874
|
5 244
|
4 858
|
178
|
686
|
962
|
735
|
2 450
|
2 855
|
|
| Total Receivables |
7 592
|
6 592
|
14 265
|
22 223
|
22 516
|
35 128
|
41 935
|
78 045
|
84 960
|
98 317
|
|
| Accounts Receivables |
2 983
|
2 861
|
3 224
|
3 270
|
6 729
|
6 979
|
5 240
|
9 057
|
13 922
|
22 937
|
|
| Other Receivables |
4 609
|
3 731
|
11 041
|
18 953
|
15 787
|
28 149
|
36 695
|
68 988
|
71 038
|
75 379
|
|
| Inventory |
56 697
|
59 176
|
61 312
|
86 499
|
135 540
|
173 261
|
222 072
|
346 825
|
361 501
|
370 186
|
|
| Other Current Assets |
11 426
|
9 392
|
15 339
|
19 780
|
16 469
|
23 774
|
33 108
|
40 164
|
61 579
|
72 507
|
|
| Total Current Assets |
82 685
|
85 811
|
107 192
|
149 801
|
193 554
|
268 197
|
348 521
|
550 683
|
599 247
|
629 798
|
|
| PP&E Net |
1 203
|
1 180
|
1 419
|
1 554
|
2 161
|
2 176
|
2 829
|
3 961
|
7 350
|
12 358
|
|
| PP&E Gross |
1 203
|
1 180
|
1 419
|
1 554
|
2 161
|
2 176
|
2 829
|
3 961
|
7 350
|
12 358
|
|
| Accumulated Depreciation |
439
|
519
|
615
|
719
|
939
|
1 043
|
1 233
|
1 584
|
1 904
|
2 429
|
|
| Intangible Assets |
440
|
403
|
398
|
494
|
638
|
709
|
830
|
880
|
1 051
|
1 755
|
|
| Goodwill |
221
|
212
|
223
|
245
|
225
|
208
|
205
|
854
|
896
|
1 022
|
|
| Note Receivable |
2 817
|
3 845
|
5 318
|
6 741
|
3 642
|
2 938
|
4 303
|
4 594
|
2 138
|
5 960
|
|
| Long-Term Investments |
5 199
|
6 598
|
10 042
|
12 086
|
12 173
|
18 494
|
23 337
|
32 190
|
42 887
|
151 892
|
|
| Other Long-Term Assets |
959
|
1 383
|
1 904
|
4 509
|
5 062
|
5 496
|
7 131
|
9 296
|
11 367
|
18 067
|
|
| Other Assets |
221
|
212
|
223
|
245
|
225
|
208
|
205
|
854
|
896
|
1 022
|
|
| Total Assets |
93 523
N/A
|
99 433
+6%
|
126 496
+27%
|
175 430
+39%
|
217 454
+24%
|
298 219
+37%
|
387 157
+30%
|
602 459
+56%
|
664 938
+10%
|
820 852
+23%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
8 272
|
7 105
|
10 031
|
10 512
|
14 751
|
21 752
|
27 903
|
41 765
|
41 065
|
59 696
|
|
| Accrued Liabilities |
1 443
|
1 564
|
1 941
|
2 900
|
4 218
|
4 082
|
4 890
|
23 752
|
35 810
|
35 241
|
|
| Short-Term Debt |
12 498
|
8 891
|
14 423
|
23 256
|
27 558
|
31 112
|
28 955
|
57 998
|
55 966
|
79 835
|
|
| Current Portion of Long-Term Debt |
3 771
|
3 202
|
4 628
|
5 448
|
5 324
|
12 234
|
14 105
|
14 630
|
17 064
|
22 383
|
|
| Other Current Liabilities |
27 473
|
33 098
|
33 836
|
41 867
|
58 923
|
97 057
|
136 715
|
218 091
|
242 104
|
259 893
|
|
| Total Current Liabilities |
53 456
|
53 859
|
64 859
|
83 983
|
110 774
|
166 237
|
212 567
|
356 236
|
392 009
|
457 048
|
|
| Long-Term Debt |
16 293
|
17 514
|
27 532
|
42 902
|
44 254
|
57 059
|
71 797
|
89 679
|
102 999
|
121 245
|
|
| Deferred Income Tax |
295
|
341
|
497
|
693
|
620
|
1 584
|
2 239
|
3 070
|
4 098
|
15 620
|
|
| Minority Interest |
5 106
|
7 575
|
11 153
|
20 121
|
26 862
|
35 474
|
47 671
|
86 074
|
106 868
|
155 128
|
|
| Other Liabilities |
1 299
|
1 049
|
907
|
4 105
|
7 389
|
5 148
|
14 496
|
16 555
|
481
|
2 300
|
|
| Total Liabilities |
76 450
N/A
|
80 338
+5%
|
104 949
+31%
|
151 804
+45%
|
189 898
+25%
|
265 503
+40%
|
348 770
+31%
|
551 615
+58%
|
606 456
+10%
|
751 341
+24%
|
|
| Equity | |||||||||||
| Common Stock |
2 835
|
2 835
|
2 835
|
2 835
|
2 835
|
2 835
|
2 864
|
2 863
|
3 005
|
3 004
|
|
| Retained Earnings |
11 536
|
13 541
|
16 004
|
18 194
|
22 306
|
26 936
|
30 131
|
34 671
|
38 611
|
48 916
|
|
| Additional Paid In Capital |
2 590
|
2 449
|
2 508
|
2 441
|
2 445
|
2 536
|
2 910
|
3 271
|
4 460
|
4 629
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
501
|
505
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
154
|
153
|
902
|
847
|
|
| Other Equity |
112
|
270
|
201
|
156
|
30
|
410
|
2 636
|
10 207
|
12 806
|
13 303
|
|
| Total Equity |
17 073
N/A
|
19 095
+12%
|
21 547
+13%
|
23 626
+10%
|
27 556
+17%
|
32 717
+19%
|
38 387
+17%
|
50 844
+32%
|
58 482
+15%
|
69 511
+19%
|
|
| Total Liabilities & Equity |
93 523
N/A
|
99 433
+6%
|
126 496
+27%
|
175 430
+39%
|
217 454
+24%
|
298 219
+37%
|
387 157
+30%
|
602 459
+56%
|
664 938
+10%
|
820 852
+23%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
2 835
|
2 835
|
2 835
|
2 835
|
2 835
|
2 835
|
2 835
|
2 835
|
2 844
|
2 853
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
